Used in pharmaceutical research as a potent and selective inhibitor of kinases involved in inflammatory and oncogenic signaling pathways. Featuring a trifluoromethyl group and multiple heterocyclic units, its structure enables strong binding affinity, improved cell permeability, metabolic stability, and specificity to biological targets, making it a valuable scaffold in medicinal chemistry for optimizing drug candidates. Shows promise in the development of targeted therapies for certain cancers, particularly those driven by dysregulated kinase activity, including resistant or mutated forms. Also investigated for use in neurodegenerative disease models due to its ability to cross the blood-brain barrier and modulate key cellular responses.